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The ovarian physiology is regulated by some complex factors such as hormones and growth factors. 
The hormones and growth factors are synthesized by follicular and ovarian cells during follicular 
maturation stage and cytokines are synthesized by the immune system. Interaction between immune 
and endocrine systems modulates ovarian
 
function through the secretion of regulatory soluble
 
factors, 
especially cytokines. There is a close contact between corona-cumulus-oocyte complex with follicular 
fluid which affects the quality and degree of oocyte maturation. The objectives of this study were to 
determine the levels of interleukin-6 (IL-6), interleukin 1β, estradiol and testosterone concentration in 
serum and follicular fluid of women with stimulated and non-stimulated ovaries. A total of 41 women, 27 
in stimulated and 14 non-stimulated cycles, undergoing intra cytoplasmic sperm injection (ICSI) 
treatment were included in this study. Follicular fluid and serum samples from all cases were collected 
at the time of oocyte retrieval and concentration of testosterone, estradiol, interleukin 6 and interleukin 
1β were measured. The results show that serum concentration of testosterone was significantly higher 
in non stimulated cases. Also, the serum and follicular fluid concentrations of interleukin 6 and 
interleukin 1β in stimulated cases were significantly higher than non stimulated group. There was an 
important negative correlation between the level of testosterone in patient's serum and IL-6 and IL-1β 
levels of follicular fluid. In conclusion, according to these results, it seems that the levels of 
testosterone and IL-6 and IL-1β in patient's serum and follicular fluid are a good factor for prediction of 
maturity of oocytes. 
 





A complex of hormones, growth factors and cytokines 
regulates the ovarian function. The interaction between 
immune and endocrine systems is triggered by
 
the action 
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function through the secretion of regu-latory 
soluble
 
factors, especially cytokines (Adashi, 1992; Zolti 
et al, 1991; Bonetti et al., 2010).  
The immune cells have been suggested to play an 
important role in ovarian physiology. They are a source of 
cytokines and growth factors within the ovary at various 
stages of follicular development (Brannstrom and 
Norman, 1993). In the pre-ovulatory stage, several kinds 
of leukocytes and cytokines seem to act synergistically to 
promote rupture of the follicle and change the ruptured 
follicle into a corpus luteum (Brannstrom and Norman, 
1993; Ziltener et al., 1993; Hammadeh et al., 2002). Also, 





process of ovulation (Adashi, 1992; Barak et al., 1992; 
Hurwitz et al., 1991; Machelon et al., 1995). 
In addition, macrophage secrets factors which play 
important roles in granulosa cell proliferation and the 
regulation of follicular steroidogenesis and follicular 
rupture (Cohen et al., 1996).  
The hormones synthesized by granulosa cells during 
follicular maturation stage accumulate in follicular fluid. It 
is believed that there is a close contact between corona-
cumulus-oocyte complex with follicular fluid and an 
association exists between the hormonal content of 
follicular fluid and the quality and degree of oocyte 
maturation. Therefore, the hormonal content of follicular 
fluid is presumed to be related to fertilization, embryo 
development and implantation rate (Costa et al., 2004; 
Fishel et al., 1983; Pellicer et al., 1998).  
In the last decade, for ovulation induction, gona-
dotropin-releasing hormone (GnRH) agonists have been 
routinely used in assisted reproductive technology (ART). 
In vivo and in vitro studies have shown that GnRH 
reduces steroidogenesis granulosa cells and reduce 
steroid levels in follicular fluid (Dor et al., 2000; Costa et 
al., 2004). On the other hand, the use of GnRH agonists 
during ovulation induction has significantly improved the 
results of ART cycles, causing the relationship between 
steroid levels and oocyte maturity to be questioned. 
Recently, some studies were carried out to determine 
whether progesterone, estradiol and cytokines levels in 
serum and follicular fluid or their ratio may be used as 
parameters to discriminate between ovulatory (mature) 
oocytes and non-ovulatory (immature) oocytes. However, 
progesterone, estradiol and testosterone levels in 
follicular fluid are significantly modified during the 
preovulatory period, especially after the luteinizing hor-
mone (LH) surge (Murdoch and Dunn, 1982; Hammadeh 
et al., 2002; Costa et al., 2004; Bonetti et al., 2010). 
However, the results were contradictory to that of Peek et 
al. (1986) and Wramsby et al. (1981). The ability to 
determine the condition of oocytes maturation during 
ovulation induction cycles is the ambition of many ART 
clinics. If this can be successfully achieved, it would aid 
women at risk of premature ovarian failure, and possibly 
result in women no longer requiring an expensive drug 
regime and monitoring programme, which they currently 
have to undergo (Thomas et al., 2003). 
The objectives of this study were to determine the 
levels of interleukin-6 (IL-6), interleukin 1β, estradiol and 
testosterone concentration in serum and follicular fluid of 
women with stimulated and non-stimulated ovaries. 
 
 
MATERIALS AND METHODS  
 
The local ethical committee approved the study and written 
informed consents were obtained from all participants according to 
the criteria of the Hamadan University of medical sciences.  
A total of 41 women, 27 in stimulated and 14 non-stimulated 
cycles, undergoing ICSI treatment in the Fatemieh Infertility 
Research Center were included in  this  study. The  age  of  all   the  




patients was under 40 years and male factor was the main 
indication for ICSI treatment. In the stimulated cases, all patients 
underwent controlled ovarian hyperstimulation after they had been 
treated with GnRH agonist (Superfact, Hoechst, Germany), for 
pituitary down-regulation as described earlier (Farimani et al., 
2006). Controlled ovarian hyperstimulation was induced with 
recombinant FSH (Gonal-F, Serono, Swiss). Administration started 
at a daily dose of 150 to 225 IU, depending on age. The dose of the 
gonadotropin was changed according to the follicular growth. When 
more than 2 follicles bigger than or equal to 18 mm were seen, 
HCG (Pregnyle, Organon, Germany) 10000 IU were injected to 
induce final oocyte maturation and 36 h later, the mature oocytes 
were retrieved.  
In the non-stimulated cases, to initiate the treatment cycle, the 
patient with amenorrhea received vaginal 300 mg of progesterone 
once daily for 10 days to induce withdrawal bleeding. Between days 
2 and 4 of menstrual bleeding, small ovarian follicles were 
monitored by transvaginal ultrasonography, confirming that there 
was no dominant follicle and endometrial thickness was 8 mm. 
Transvaginal ultrasound scans were repeated on day 8 of the cycle 
or on the day of HCG administration (Chian et al., 2000; Son et al., 
2006) when endometrial thickness reached at least 6 mm.  
The patient was given 10000 IU of HCG 
(Pregnyle,Organon,Germany) and 36 h later, the immature oocytes 
were retrieved (Chian et al., 2000). Immature oocytes were 
aspirated with 17.5 gauge needles (MDT, Netherlands) under the 
guidance of transvaginal ultrasonography. A portable aspiration 
pump was used with a pressure between 160 and 180 mmHg. The 
aspirates were collected in tubes with pre-warmed heparinized 
saline, immature oocytes were retrieved and follicular fluid was 
collected.  
Follicular fluid samples from 27 stimulated and 14 non-stimulated 
cases were collected at the time of oocyte retrieval and immediately 
centrifuged (10 min by 300 g) to remove granulose cells and 
clarified supernatants. Then, the supernatants were collected and 
stored in aliquots at -70°C until the hormones and cytokines 
concentration were determined. Only follicular fluid free of blood 
was used to determine cytokine and hormone determination.  
A peripheral blood sample was obtained from all the cases on the 
day of oocyte retrieval. The serum were separated and stored at -
70°C for further analysis. 
 
 
Testosterone and estradiol assay 
 
Serum and follicular fluid testosterone and estradiol were measured 
using a quantitative competitive immuno-assay kit (DRG 
instruments company, Germany). Testosterone and estradiol were 
analyzed in duplicate for each serum samples. 
The level of testosterone is expressed as ng/ml, the level of 
estradiol is expressed as pg/ml.  
 
 
Interleukin 6 and interleukin 1β assay 
 
Both serum and follicular fluid Interleukin 6 and interleukin 1β were 
measured using enzyme linked immunosorbent assay for 
quantitative detection of human interleukin 6 and interleukin 1β 
(Bender Med Systems, Austria) (IL-6 BMS 213/2 and IL-1β BMS 






Statistical analysis was performed using the SPSS software 
package, version  16.  Student  t-test  was  used  for  analysis.  The  




Table 1. The levels of testosterone, estradiol, interleukin 6 and interleukin 1β in the serum of 




(mean ± SEM) 
Non-stimulated 
(mean ± SEM) 
P- value 
Testosterone (ng/ml) 7.90±1.04 13.93±1.37 <0.001 
Estradiol (pg/ml) 1518.2±5.64 1513.8±9.27 <0.672 
Interleukin 6 (pg/ml) 1.80±0.26 0.21 ±0.05 0.000 




Table 2. The levels of testosterone, estradiol, interleukin 6 and interleukin 1β in the follicular fluid of 




(mean ± SEM) 
Non-Stimulated 
(mean ± SEM) 
P- value 
Testosterone (ng/ml) 2.24±0.19 3.43±0.36 <0.003 
Estradiol (pg/ml) 1207± 70.65 1102.4 ± 129.42 <0.443 
Interleukin 6 (pg/ml) 9.08 ±0.58 2.32 ±0.7 0.000 




results were reported as mean ± SEM. The linear dependence was 
measured using Pearson’s correlation coefficient. A value of P<0.05 





The study population consisted of 41 patient serum and 
follicular fluid, 27 patients with stimulated and 14 patient 
non-stimulated ovaries. The mean ± SEM and differences 
of testosterone, estradiol and cytokines in the serum and 
follicular fluids of both groups are shown in Tables 1and 
2.  
As shown in these tables, the level of testosterone in 
serum and follicular fluid of non stimulated group were 
significantly higher than that of stimulated (P<0.001 and 
P<0.003, respectively). However, there were no 
significant differences between the levels of estradiol in 
serum and follicular fluid of two groups. In comparing the 
concentration of cytokines, significant difference was 
shown between the groups. As shown in Tables 1 and 2, 
the levels of interleukin 6 and interleukin 1β in serum and 
follicular fluid of stimulated cases were significantly 
higher than non-stimulated group(P<0.000). 
On the other hand, the statistical analysis of our results 
showed that the serum concentration of testosterone was 
negatively correlated with the concentration of IL-6 in 
follicular fluid (P<0.006, r = -0.425) (Figure 1). The same 
result was shown on the correlation between the serum 
concentration of testosterone and level of interleukin 1β 
in follicular fluid (P<0.006, r = - 0.468) (Figure 2) but there 
were no correlation between serum concentration of 
estradiol and level of interleukin 6 and interleukin 1β in 





The statistical analysis of our results showed that serum 
concentration of testosterone in non stimulated cases 
was significantly higher than that of stimulated patients. 
On the other hand, there was an important negative 
correlation between the level of testosterone in patient's 
serum and IL-6 and IL-1β levels of follicular fluid, but 
there is no correlation between the level of estradiol in 
patient serum and IL-6 and IL-1β levels of follicular fluid. 
According to our results, it seems that the levels of 
testosterone in patient serum are negatively correlated 
with the maturity of oocytes. However, we could not find a 
cut off point in the level of serum testosterone to predict 
the maturity of oocytes.  
Several studies have shown that mature oocytes with a 
higher potential for fertilization  are  also  associated  with  








Figure 1.  Negative correlation between the serum concentration of 
testosterone and level of interleukin 6 in follicular fluid (FF) of study 











Figure 2. Negative correlation between the serum concentration of 
testosterone and level of interleukin 1β in follicular fluid (FF) of study 




lower testosterone levels in follicular fluid at the time of 
follicular rupture (Brailly et al., 1981; Vanluchene et al., 
1991; Costa et al., 2004). Our results are in agreement 
with these data. The association between oocyte maturity 
and low testosterone concentration in follicular fluid of 
stimulated cases is usually associated with immature 
oocyte with low count of granulosa cells. Estradiol levels 
were not different between mature and immature 
oocytes. The reduction of estradiol levels in preovulatory 
follicles   seems   to  result   from  a  modification  of  the  




steroidogenic patterns of granulosa cells. Oocyte 
maturation is accompanied by a significant reduction in 
estradiol and testosterone levels and a positive 
association between them. Indeed, this could not be 
different, since androgens and testosterone in particular 
are immediate precursors of estradiol. Thus, if a 
reduction in testosterone production by thecal cells is 
observed, this fact definitely contributes to the reduction 
of estrogen synthesis observed in parallel (Costa et al., 
2004). 
Previous reports have indicated that IL-6 and IL-1β 
have an important role in ovarian steroidogenesis, while it 
is known that these cytokines are produced by ovarian 
granulosa cells of preovulatory follicles (Salamonsen et 
al., 2007; Trundley et al., 2004), being a main mediator of 
inflammatory responses during ovulation (Buscher et al., 
1999). 
In conclusion, it seems that lower levels of cytokines in 
follicular fluid of immature oocytes indicate their role in 
follicular growth and oocyte maturation. For the time 
being, we are unable to provide a cut off point in levels of 
IL-6 and IL-1β in serum and follicular fluid to predict the 
maturity of oocytes and future studies are needed to find 
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